Loading...
01/11 11:26
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company reported strong financial performance with significant revenue and net profit growth, driven by AI integration and business expansion. Despite increased operating costs, profitability improved, supported by shareholder returns through dividends and share repurchases. However, risks include rising expenses and regulatory uncertainties, but optimistic guidance and strategic AI investments suggest positive sentiment. The absence of any negative sentiment from the Q&A further supports a positive outlook.
Overall Revenue RMB 975 million, marking a year-on-year growth of 38.4%. This reflects a strong growth trajectory.
Insurance Business Revenue RMB 870 million, up 44.8% year-on-year. Growth attributed to optimized real-time identification capabilities and integration of data links among advertising, operation, and risk control systems.
Crowdfunding Service Fees RMB 65.66 million, remaining stable year-on-year.
Digital Clinical Trial Solutions Income RMB 31.85 million, marking a 31.3% year-on-year increase. Growth driven by enhanced digital matching accuracy and refined project operations.
Operating Costs and Expenses RMB 861 million, marking a year-on-year increase of 27.1%. Growth rate of operating cost was lower than the revenue growth, further boosting profitability.
Operating Costs RMB 475 million, up 39.5% year-on-year. Driven by RMB 66.7 million rise in cost of referral and service fees, along with RMB 32.4 million and RMB 16.9 million increase in personnel costs and the cost of performing consultant fees.
Sales and Marketing Expenses RMB 243 million, rising 40.3% year-on-year. Mainly due to enhanced AI application improving user identification accuracy and conversion rate, leading to increased traffic investment.
General and Administrative Expenses RMB 84.7 million, declined 23.7% year-on-year. Key factors include a RMB 15.6 million reduction in personnel costs and the absence of last year's RMB 20.6 million impairment loss.
R&D Expenses RMB 58.3 million, rose 10.2% year-on-year. Personnel costs and cross-server expense and other technical support expenses increased by RMB 3.2 million and RMB 2.7 million, respectively.
Operating Profit RMB 114 million, marking a substantial year-on-year increase of 329.8%.
Net Profit Attributable to Ordinary Shareholders RMB 158 million, up 60.1% year-on-year. Growth driven by enhanced business quality and efficiency through AI.
Cash Position RMB 3.51 billion as of the end of the period. Net operating cash flow remained positive, providing firm financial support for business expansion and technological development.
Quan Jia Fu Family Protection Plan: Covers up to nine family members under one single policy.
Guo Min Bao Mid-to-High-End Medical Insurance: Upgraded with an expanded network of quality private hospitals.
Shou Hu series: Introduced modular options tailored to diverse budget needs for critical illness insurance.
Wu You Shou Hu disability insurance series: Upgraded to achieve comprehensive coverage.
Insurance-related revenue: Reached about CNY 870 million, increasing by 44.8% year-on-year and 17.8% quarter-on-quarter.
Pre-existing condition insurance: Contributed about CNY 400 million in FIP, a year-on-year increase of 103.9%.
Digital Clinical Trial solutions: Income reached RMB 31.85 million, marking a 31.3% year-on-year increase.
AI integration in insurance: Enhanced operational efficiency, including reducing underwriting response time from 5 minutes to 1 second and achieving 36% sequential increase in facilitated FIP.
AI-powered customer service: Handled over 600,000 insurers in one month, solving 85% of online cases independently.
Waterdrop C-Point AI: Launched as a low-code AI platform to empower employees in building and deploying tailored solutions.
AI advancements: Filed 69 patent applications centered on large language models, including nine international filings.
ESG measures: Updated ESG governance framework and released the 2024 annual ESG report.
Public welfare initiatives: Collaborated with 119 charities and launched over 15,500 projects, including the Waterdrop Co-Help program.
Forward-looking statements: The company acknowledges that forward-looking statements are subject to risks and uncertainties, which may cause actual results to differ materially from expectations. These risks include market conditions, regulatory changes, and other uncertainties.
Operating costs and expenses: Operating costs and expenses increased by 27.1% year-on-year, driven by rises in referral and service fees, personnel costs, and consultant fees. This could impact profitability if revenue growth slows.
Sales and marketing expenses: Sales and marketing expenses rose by 40.3% year-on-year due to increased traffic investment and enhanced AI applications. This could strain financial resources if conversion rates do not justify the expenditure.
R&D expenses: R&D expenses increased by 10.2% year-on-year, driven by higher personnel and technical support costs. Sustained increases in R&D spending could pressure margins if not offset by revenue growth.
Crowdfunding platform risk control: The company has focused on strengthening campaign risk control measures to reduce fraud and improve transparency. However, the need for such measures indicates potential risks related to fraud and misuse of funds.
AI investment and integration: Significant investment in AI, including patent applications and platform development, poses a risk if these technologies fail to deliver expected efficiencies or competitive advantages.
Regulatory and compliance risks: The company operates in sectors like insurance and healthcare, which are subject to stringent regulatory requirements. Non-compliance could lead to legal and financial repercussions.
Economic uncertainties: Broader economic conditions could impact the company's operations, particularly in areas like insurance and crowdfunding, which are sensitive to consumer spending and economic stability.
Revenue and Profit Guidance: The company is confident in exceeding full-year revenue and profit guidance, building on robust business performance.
AI Integration and Innovation: The company plans to leverage advancing AI technologies to drive integration and innovation across operations, fueling sustainable long-term growth.
Insurance Business Growth: Insurance-related revenue is expected to continue its significant growth momentum, supported by product innovation, AI deployment, and enhanced operational efficiency.
AI-Powered Insurance Services: AI applications in insurance services, such as underwriting, pre-sales, and after-sales, are expected to enhance efficiency and maintain higher performance metrics compared to human agents.
Expansion of Digital Clinical Trial Solutions: The company aims to enhance digital matching accuracy between patient databases and project libraries, driving sustained order growth and expanding disease coverage into new areas like rheumatology and immunology.
Healthcare Business Growth: The healthcare business plans to expand its collaboration network and improve service efficiency through advanced digital capabilities and AI-powered applications.
Cash Dividend Distribution: In early November, the company completed its fourth cash dividend distribution since IPO, with a total payout of around $10.9 million.
Share Repurchase: By the end of November 2025, the company had repurchased approximately 58.1 million ADS in the open market, totaling $113 million.
The company reported strong financial performance with significant revenue and net profit growth, driven by AI integration and business expansion. Despite increased operating costs, profitability improved, supported by shareholder returns through dividends and share repurchases. However, risks include rising expenses and regulatory uncertainties, but optimistic guidance and strategic AI investments suggest positive sentiment. The absence of any negative sentiment from the Q&A further supports a positive outlook.
The company reported strong financial performance with significant revenue and profit growth, driven by AI integration. Enhanced shareholder returns through increased dividends and share repurchases are positive signals. Despite potential risks like regulatory hurdles and economic uncertainties, the optimistic guidance and operational efficiency improvements outweigh concerns. The sentiment from the Q&A section did not provide additional negative insights to alter the positive outlook.
The earnings call highlights strong financial performance, including a significant increase in net profit and stable operating margins. The company is expanding AI investments and partnerships, which are positive for future growth. Shareholder returns through dividends and share repurchases further boost sentiment. Despite some regulatory and competitive risks, the overall outlook remains positive with strategic investments and a solid cash position supporting growth. The absence of significant concerns in the Q&A session reinforces this sentiment.
The earnings call reflects strong financial performance with substantial revenue and profit growth, supported by strategic AI investments and shareholder returns through dividends and repurchases. Despite regulatory and competitive risks, the company's robust cash position and operational efficiency improvements suggest positive momentum. The market is likely to react positively, driven by optimistic growth outlooks and strategic initiatives.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
